No Data
Deutsche Bank Initiates Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Announces Target Price $12
Deutsche Bank Initiates Coverage on Avadel Pharmaceuticals With Buy Rating, $12 Price Target
Health Check: How Prudently Does Avadel Pharmaceuticals (NASDAQ:AVDL) Use Debt?
Express News | Avadel Pharmaceuticals PLC : Deutsche Bank Initiates Coverage With Buy Rating; Price Target $12
Avadel Pharmaceuticals Gains as Holder Pushes for Sale Process
ASL Strategic Value Fund Letter to Avadel Pharmaceuticals (AVDL: NASDAQ) Board of Directors